000 | nab a22 7a 4500 | ||
---|---|---|---|
999 |
_c17384 _d17384 |
||
003 | PC17384 | ||
005 | 20230414115349.0 | ||
008 | 230414b xxu||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aeng | ||
100 |
_91025 _aFlores de la Cal, Ana Isabel _eBanco de Sangre de Cordón Umbilical |
||
100 |
_9339 _aGómez Gómez, Gonzalo Jesús _eAparato Digestivo |
||
100 |
_92286 _aMasedo González, Ángeles _eAparato Digestivo |
||
100 |
_9621 _aMartínez Montiel, Pilar _eAparato Digestivo |
||
245 | 0 | 0 |
_aStem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?. _h[revisión] |
260 |
_bWorld journal of stem cells, _c2015 |
||
300 | _a7(2):343-51. | ||
500 | _aFormato Vancouver: Flores AI, Gómez Gómez GJ, Masedo González Á, Martínez Montiel MP. Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?. World J Stem Cells. 2015 Mar 26;7(2):343-51. | ||
501 | _aPMID: 25815119 PMC4369491 | ||
504 | _aContiene 84 referencias | ||
520 | _aInflammatory bowel diseases are inflammatory, chronic and progressive diseases of the intestinal tract for which no curative treatment is available. Research in other fields with stem cells of different sources and with immunoregulatory cells (regulatory T-lymphocytes and dendritic T-cells) opens up new expectations for their use in these diseases. The goal for stem cell-based therapy is to provide a permanent cure. To achieve this, it will be necessary to obtain a cellular product, original or genetically modified, that has a high migration capacity and homes into the intestine, has high survival after transplantation, regulates the immune reaction while not being visible to the patient's immune system, and repairs the injured tissue. | ||
710 |
_9273 _aServicio de Medicina del Aparato Digestivo |
||
710 |
_9625 _aInstituto de Investigación imas12 |
||
856 |
_uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369491/ _yAcceso libre |
||
942 |
_2ddc _cREV _n0 |